Upconversion nanoparticle-based micelles for neuroendocrine tumor theranostics.
Upconversion nanoparticle-based micelles for neuroendocrine tumor theranostics.
Research highlights from this month’s Advanced Healthcare Materials issues.
Ever take a good look at your shoelaces?
Metal nanoparticles have demonstrated broad and promising biomedical applications in research laboratories, but to fulfill their potential in the clinic demands extensive effort to minimize their non‐specific accumulation in the body.
Liposomal formulations of two novel nicotinylated amphiphiles for targeting potent chemotherapeutics to mouse glioblastoma.
Using a proteomics approach, Drs. Paulo and Gygi from the Harvard Medical School provide evidence that nicotine exposure changes the abundance of membrane proteins implicated in signal transduction and autophagy.
In an effort to overcome barriers to the treatment of glioblastoma (GBM), targeted nanotherapeutics have emerged as promising drug delivery systems with the potential to improve pharmacokinetic profiles and therapeutic efficacy.
Scientists from Tomsk Polytechnic University have obtained magnetic stem cells with low toxicity and enough stable for gene engineering applications.
Silver nanoparticles are a more effective cancer treatment in immune competent mice.
A novel melanin-based contrast agent may help assess the tumor vasculature after antiangiogenic treatment via Dynamic Contrast Enhanced Photoacoustic Imaging.